DBS Remains a Buy on Mapletree Industrial (MAPIF)
In a report released today, Derek Tan from DBS maintained a Buy rating on Mapletree Industrial (MAPIF – Research Report), with a price target of S$2.60. The company's shares closed last Tuesday at $1.73.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
According to TipRanks, Tan is an analyst with an average return of -2.1% and a 37.50% success rate. Tan covers the Real Estate sector, focusing on stocks such as Capitaland India Trust, Mapletree Industrial, and City Developments.
Currently, the analyst consensus on Mapletree Industrial is a Moderate Buy with an average price target of $1.84.
Based on Mapletree Industrial's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $169.89 million and a net profit of $95.26 million. In comparison, last year the company earned a revenue of $164.23 million and had a net profit of $95.31 million
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
3 hours ago
- Business Insider
PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen
In a report released yesterday, Josh Jennings from TD Cowen reiterated a Buy rating on PROCEPT BioRobotics (PRCT – Research Report). The company's shares closed yesterday at $65.05. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Jennings covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Medtronic, and Establishment Labs Holdings. According to TipRanks, Jennings has an average return of 4.6% and a 52.11% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for PROCEPT BioRobotics with a $80.20 average price target. PRCT market cap is currently $3.32B and has a P/E ratio of -36.24. Based on the recent corporate insider activity of 43 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PRCT in relation to earlier this year. Most recently, in March 2025, Reza Zadno, the President & CEO of PRCT sold 5,475.00 shares for a total of $312,403.50.
Business Insider
3 hours ago
- Business Insider
Stifel Nicolaus Keeps Their Buy Rating on Kymera Therapeutics (KYMR)
analyst Alex Thompson CFA maintained a Buy rating on Kymera Therapeutics (KYMR – Research Report) yesterday and set a price target of $68.00. The company's shares closed yesterday at $47.66. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Thompson CFA covers the Healthcare sector, focusing on stocks such as Kymera Therapeutics, Oruka Therapeutics, and Travere Therapeutics. According to TipRanks, Thompson CFA has an average return of -2.8% and a 45.45% success rate on recommended stocks. In addition to Stifel Nicolaus, Kymera Therapeutics also received a Buy from UBS's Eliana Merle in a report issued on June 3. However, on May 30, Bank of America Securities maintained a Hold rating on Kymera Therapeutics (NASDAQ: KYMR). The company has a one-year high of $53.27 and a one-year low of $19.45. Currently, Kymera Therapeutics has an average volume of 856.8K.
Yahoo
3 hours ago
- Yahoo
Intel draws a line in the sand to boost gross margins — new products must deliver 50% gross profit to get the green light
When you buy through links on our articles, Future and its syndication partners may earn a commission. Intel will not be entertaining any projects that do not promise to double its money going forward. Michelle Johnston Holthaus, CEO of Intel Products, announced at Bank of America's global technology conference that Intel is no longer approving new projects that cannot be proven to earn at least 50% gross margin "based on a set of industry expectations." Holthaus explained Intel's new risk-averse policy as "something that we probably should have had before, but we have it now so that product doesn't move forward; you actually don't get engineers assigned to it if it's not 50% or higher gross margins moving forward." Holthaus also clarified that while Intel is not expecting or projecting 50% gross margins across all operations, it is a number the company is aspiring toward internally. All of Intel's future roadmap operations, including Panther Lake and Nova Lake, are also currently expected to reach the 50% gross profit number that the rest of the business aspires to. The drive behind this initiative is reportedly coming from Intel's new CEO, Lip-Bu Tan. Tan is reportedly "laser focused on the fact that we need to get our gross margins back up above 50%." To accomplish this, Tan is also said to be investigating and potentially cancelling or changing unprofitable deals with other companies. Intel's margins have slipped to new lows for the company in recent months. MacroTrends reports Intel's trailing 12 months gross margin for Q1 2025 was as low as 31.67%. Intel's gross margins had hovered around the 60% mark for the ten years leading up to the COVID-19 pandemic, falling beneath 50% in Q2 2022 and continuing to steadily fall ever since. Holthaus predicts a "tug-of-war" to ensue within Intel in the coming months as engineers and executives reckon with being forced between a rock and a hard place. "We need to be building products that... fit the right competitive landscape and requirements of our customers, but also have the right cost structure in place. It really requires us to do both." CEO Lip-Bu Tan has done much to streamline Intel's operation and right a rocking ship inherited from previous Intel chief Pat Gelsinger. Another major round of layoffs, potentially up to 20% of the remaining workforce, is coming in Q2, arriving after a major leadership change-up to remove middle management between Tan and other team leads. Tan is also quoted as wanting to turn Intel into an "engineering-focused company" again under his leadership. To reach this, Tan has committed to investing in recruiting and retaining top talent; "I believe Intel has lost some of this talent over the years; I want to create a culture of innovation empowerment." Maintaining a culture of empowering innovation and top talent seems, on its face, at odds with layoffs and a lock on projects not projected to gross 50% margins, but Tan seemingly has Intel investors on his side in these pursuits. Follow Tom's Hardware on Google News to get our up-to-date news, analysis, and reviews in your feeds. Make sure to click the Follow button. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
